Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

2.0K
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
2.0K
Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

44
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
44
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

40
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
40

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A multicenter performance evaluation of aztreonam-avibactam gradient diffusion susceptibility testing for <i>Enterobacterales</i>.

Journal of clinical microbiology·2026
Same author

Assessing antimicrobial susceptibility testing guideline adherence by laboratories providing bacteriology services in Ghana: a pilot study.

The Journal of antimicrobial chemotherapy·2026
Same author

How to: the application and analysis of categorical agreement in antimicrobial susceptibility testing using European Committee on Antimicrobial Susceptibility Testing breakpoints.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2025
Same author

Importance of reviewing the package insert from gradient strip manufacturers.

The Journal of antimicrobial chemotherapy·2025
Same author

Rifampicin as monotherapy for infections caused by Staphylococcus aureus: considerations for not applying 'breakpoints in brackets'.

The Journal of antimicrobial chemotherapy·2025
Same author

Glycopeptide Heteroresistance Among Coagulase-Negative Staphylococci: A Systematic Review and Meta-analysis.

Open forum infectious diseases·2025

Related Experiment Video

Updated: Apr 3, 2026

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

28.0K

Antimicrobial susceptibility testing breakpoints and methods from BSAC to EUCAST.

Derek F J Brown1, Mandy Wootton2, Robin A Howe2

  • 1EUCAST, Peterborough, UK derek.brown222@btinternet.com.

The Journal of Antimicrobial Chemotherapy
|September 18, 2015
PubMed
Summary
This summary is machine-generated.

European laboratories are harmonizing antimicrobial susceptibility testing (AST) breakpoints. This standardization, led by the European Committee on Antimicrobial Susceptibility Testing (EUCAST), improves data consistency for antimicrobial resistance surveillance.

More Related Videos

A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically
11:28

A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically

Published on: September 9, 2015

30.0K
Antimicrobial Susceptibility Testing of Mycobacterium Tuberculosis Complex for First and Second Line Drugs by Broth Dilution in a Microtiter Plate Format
12:39

Antimicrobial Susceptibility Testing of Mycobacterium Tuberculosis Complex for First and Second Line Drugs by Broth Dilution in a Microtiter Plate Format

Published on: June 24, 2011

39.0K

Related Experiment Videos

Last Updated: Apr 3, 2026

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

28.0K
A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically
11:28

A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically

Published on: September 9, 2015

30.0K
Antimicrobial Susceptibility Testing of Mycobacterium Tuberculosis Complex for First and Second Line Drugs by Broth Dilution in a Microtiter Plate Format
12:39

Antimicrobial Susceptibility Testing of Mycobacterium Tuberculosis Complex for First and Second Line Drugs by Broth Dilution in a Microtiter Plate Format

Published on: June 24, 2011

39.0K

Area of Science:

  • Microbiology
  • Clinical Pharmacology
  • Infectious Diseases

Background:

  • European national committees, including the BSAC, initiated harmonization of antimicrobial susceptibility testing (AST) clinical MIC breakpoints in 2002.
  • The European Committee on Antimicrobial Susceptibility Testing (EUCAST) has since established breakpoints for new antimicrobial agents following EMA guidelines.
  • EUCAST breakpoints are now widely adopted by European laboratories.

Purpose of the Study:

  • To describe the harmonization of clinical MIC breakpoints for antimicrobial susceptibility testing in Europe.
  • To highlight the adoption and implementation of EUCAST breakpoints by national committees and laboratories.
  • To emphasize the benefits of harmonized breakpoints for international surveillance and reporting.

Main Methods:

  • Harmonization of clinical MIC breakpoints for commonly used and new antimicrobial agents.
  • Adoption and implementation of EUCAST breakpoints by the BSAC into its disc diffusion susceptibility testing method.
  • Transition from national disc diffusion methods to the standardized EUCAST disc diffusion method.

Main Results:

  • Harmonization of breakpoints is complete for common agents and ongoing for new agents.
  • The BSAC has implemented EUCAST breakpoints and will phase out support for its own disc diffusion method by January 2016.
  • EUCAST breakpoints are accessible through automated systems, facilitating widespread use.

Conclusions:

  • Harmonized antimicrobial susceptibility testing breakpoints and methods prevent discrepancies in susceptibility reporting across different countries.
  • Standardization enhances the reliability of antimicrobial resistance rate comparisons in international surveillance studies.
  • The adoption of EUCAST breakpoints promotes consistent patient management and public health strategies regarding antimicrobial resistance.